Safety and Antihypertensive Effect of Selara® (Eplerenone): Results from a Postmarketing Surveillance in Japan

Figure 2

Changes in systolic blood pressure (mean ± standard deviation) from baseline to each observation time point during the 12-week treatment period in the effectiveness analysis population. The number of patients at each time point is indicated by the SBP levels under the chart.